MedPath

NEOVACS

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Study of IFN-K in Dermatomyositis

Phase 2
Withdrawn
Conditions
Dermatomyositis
Interventions
Biological: IFN-Kinoid
Other: Placebo
Other: ISA 51
First Posted Date
2016-12-02
Last Posted Date
2020-01-03
Lead Sponsor
Neovacs
Registration Number
NCT02980198
Locations
🇨🇭

Research site, Lausanne, Switzerland

🇩🇪

Charité - Universitätsmedizin Berlin Rudolf- Virchow- Haus, Berlin, Germany

Phase IIb Study of IFN-K in Systemic Lupus Erythematosus

Phase 2
Terminated
Conditions
Systemic Lupus Erythematosus
Interventions
Biological: IFNα-Kinoid
Other: Placebo
Other: ISA 51 VG
First Posted Date
2016-01-27
Last Posted Date
2020-04-09
Lead Sponsor
Neovacs
Target Recruit Count
185
Registration Number
NCT02665364
Locations
🇩🇪

Research site, Bad-Nauheim, Germany

🇹🇳

Research Site, Tunis, Tunisia

Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
Other: Placebo
Biological: TNF-Kinoid
First Posted Date
2013-07-30
Last Posted Date
2019-03-22
Lead Sponsor
Neovacs
Target Recruit Count
143
Registration Number
NCT01911234
Locations
🇱🇧

Hammoud Hospital Univeristy Medical Center, Sidon, Lebanon

🇭🇺

BKS Research Kft. Albert Schweitzer Kórhaz es Rendelőintezet-3. emelet, Hatvan, Hungary

🇧🇪

Cliniques Universitaires Saint Luc, Brussels, Belgium

and more 28 locations

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

Phase 2
Completed
Conditions
Crohn's Disease
Interventions
Biological: WFI
Biological: TNF Kinoid
First Posted Date
2011-02-08
Last Posted Date
2014-09-18
Lead Sponsor
Neovacs
Target Recruit Count
66
Registration Number
NCT01291810
Locations
🇧🇪

Imelda Clinic, Bonheiden, Belgium

🇧🇪

Cliniques Universitaires St Luc, Brussels, Belgium

🇫🇷

Hôpital Haut-Lévêque, Bordeaux, France

and more 55 locations

Safety of IFNa Kinoid in Systemic Lupus Erythematosus

Phase 1
Completed
Conditions
Systemic Lupus Erythematosus
Interventions
Biological: IFN-K
First Posted Date
2010-01-28
Last Posted Date
2019-03-21
Lead Sponsor
Neovacs
Target Recruit Count
28
Registration Number
NCT01058343
Locations
🇭🇷

University Hospital Split, Split, Croatia

🇧🇪

Cliniques Universitaires St Luc, Brussels, Belgium

🇨🇭

Geneva University Hospital, Geneva, Switzerland

and more 11 locations

Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists

Phase 2
Completed
Conditions
Rheumatoid Arthritis
Interventions
Biological: TNFa Kinoid
Biological: TNF kinoid
First Posted Date
2009-12-30
Last Posted Date
2014-09-18
Lead Sponsor
Neovacs
Target Recruit Count
40
Registration Number
NCT01040715
Locations
🇷🇴

Rehabilitation Clinical Hospital Iasi, Iasi, Romania

🇧🇪

Universiteit ZiekenHuis Katholiek Universiteit Leuven, Leuven, Belgium

🇨🇱

"Sociedad Médica del Aparato Locomotor SA", Santiago de Chile, Chile

and more 32 locations

Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease

Phase 1
Completed
Conditions
Crohn's Disease
Interventions
Biological: TNFa Kinoid
First Posted Date
2008-12-15
Last Posted Date
2011-06-08
Lead Sponsor
Neovacs
Target Recruit Count
21
Registration Number
NCT00808262
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

🇨🇭

Universitätsspital Zürich, Zurich, Switzerland

🇿🇦

Parexel Port Elizabeth, Port Elizabeth, Eastern Cape, South Africa

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath